Preview Mode Links will not work in preview mode

The Infection Prevention Strategy (TIPS)

Aug 19, 2021

Elizabeth “EC” Caley and Sam Molyneux have both made a career of working with large, complex data sets, and deconvoluting them to ask simple questions. Whether researching the genetic drivers that cause normal tissues to become cancerous, analyzing vast amounts of scientific literature, or identifying the missing data preventing the next breakthrough, EC and Sam have been aligned in their goal to use information to make a meaningful impact on people’s lives.

A few years ago, EC and Sam began to ponder the health effects of pathogens in the indoor environment. EC’s background had exposed her to the business impacts of pathogens on organizations both large and small. And like all of us, they had both seen the impact the seasonal flu or the common cold could have on their teams. They remarked that there’s incredible biotechnology that allows for precise identification of organisms, and methods to quantify, sample and analyze data around them. They wondered why these technologies and techniques, so commonly used in clinical labs, research, and genomics, were not being deployed for the indoor environment. This gap became the next problem for Sam and EC to solve together, and Poppy was born.

On this episode, we talk with EC and Sam, Co-founders, and Co-CEOs of Poppy, about the importance of understanding indoor air quality. This, of course, is tremendously important and obvious during the COVID-19 pandemic (especially with the growing evidence that SARS-CoV-2 may be primarily transmitted by aerosols). However, it has always been this important and always will be. We spend much of our time indoors and the quality of those spaces has a dramatic impact on our health and wellbeing. We get into the why, the science and technology (which is fascinating), the potential for impact and scale (which is tremendous), and more...

Visit for complete show notes.

Learn more about Poppy: